164 related articles for article (PubMed ID: 19203569)
1. Bioequivalence evaluation of two strengths of risperidone tablet formulations in healthy volunteers.
Cánovas M; Delgadillo J; Torres F; Riba N; Cebrecos J; Pelagio P; Cabré F
Int J Clin Pharmacol Ther; 2009 Feb; 47(2):124-31. PubMed ID: 19203569
[TBL] [Abstract][Full Text] [Related]
2. Lack of bioequivalence between generic risperidone oral solution and originator risperidone tablets.
van Os S; Relleke M; Piniella PM
Int J Clin Pharmacol Ther; 2007 May; 45(5):293-9. PubMed ID: 17542352
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic comparison of fast-disintegrating and conventional tablet formulations of risperidone in healthy volunteers.
van Schaick EA; Lechat P; Remmerie BM; Ko G; Lasseter KC; Mannaert E
Clin Ther; 2003 Jun; 25(6):1687-99. PubMed ID: 12860492
[TBL] [Abstract][Full Text] [Related]
4. Comparative bioavailability of two risperidone orodispersible tablet products after single dose administration.
Tassaneeyakul W; Kumar S; Gaysonsiri D; Kaewkamson T; Khuroo A; Tangsucharit P; Phunikhom K; Vannaprasaht S; Kanjanawart S; Rao Thudi N; Jain R; Reyar S; Monif T
Int J Clin Pharmacol Ther; 2010 Sep; 48(9):614-20. PubMed ID: 20860915
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence study of two limaprost alfadex 5 microg tablets in healthy subjects: moisture-resistant tablet (dextran formulation) versus standard tablet (lactose formulation).
Nakade S; Komaba J; Ohno T; Kitagawa J; Furukawa K; Miyata Y
Int J Clin Pharmacol Ther; 2008 Jan; 46(1):42-7. PubMed ID: 18218297
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence and pharmacokinetic evaluation of two formulations of risperidone 2 mg : an open-label, single-dose, fasting, randomized-sequence, two-way crossover study in healthy male Chinese volunteers.
Liu Y; Zhang MQ; Jia JY; Liu YM; Liu GY; Li SJ; Wang W; Weng LP; Yu C
Drugs R D; 2013 Mar; 13(1):29-36. PubMed ID: 23322527
[TBL] [Abstract][Full Text] [Related]
7. Risperidone: effects of formulations on oral bioavailability.
Gutierrez R; Lee PI; Huang ML; Woestenborghs R
Pharmacotherapy; 1997; 17(3):599-605. PubMed ID: 9165565
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetics and bioequivalence of two tablet formulations of 2 mg risperidone in healthy Thai male volunteers.
Khorana N; Maphanta S; Lohitnavy O; Srichaiya A; Sayasathid J
Int J Clin Pharmacol Ther; 2011 Jun; 49(6):409-14. PubMed ID: 21612749
[TBL] [Abstract][Full Text] [Related]
9. A single-dose, randomized, two-way crossover study comparing two olanzapine tablet products in healthy adult male volunteers under fasting conditions.
Elshafeey AH; Elsherbiny MA; Fathallah MM
Clin Ther; 2009 Mar; 31(3):600-8. PubMed ID: 19393850
[TBL] [Abstract][Full Text] [Related]
10. Comparative fasting bioavailability of dispersible and conventional tablets of risperidone: a single-dose, randomized-sequence, open-label, two-period crossover study in healthy male Chinese volunteers.
Huang M; Shen-Tu J; Hu X; Chen J; Liu J; Wu L
Clin Ther; 2012 Jun; 34(6):1432-9. PubMed ID: 22595151
[TBL] [Abstract][Full Text] [Related]
11. Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability.
Thyssen A; Remmerie B; D'Hoore P; Kushner S; Mannaert E
Clin Ther; 2007 Feb; 29(2):290-304. PubMed ID: 17472821
[TBL] [Abstract][Full Text] [Related]
12. Bioequivalence evaluation of two oral formulations of quetiapine fumarate in healthy volunteers.
Cánovas M; Torres F; Domenech G; Cebrecos J; Pelagio P; Martínez G; Polonio F; Cabré F
Arzneimittelforschung; 2011; 61(9):489-93. PubMed ID: 22029223
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and bioequivalence evaluation of risperidone in healthy male subjects with different CYP2D6 genotypes.
Cho HY; Lee YB
Arch Pharm Res; 2006 Jun; 29(6):525-33. PubMed ID: 16833023
[TBL] [Abstract][Full Text] [Related]
14. Relative bioavailability of two oral formulations of risperidone 2 mg: A single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Brazilian volunteers.
Belotto KC; Raposo NR; Ferreira AS; Gattaz WF
Clin Ther; 2010 Nov; 32(12):2106-15. PubMed ID: 21118746
[TBL] [Abstract][Full Text] [Related]
15. Bioequivalence evaluation of two dosage forms of olanzapine 10 mg formulations in healthy volunteers.
Cánovas M; Torres F; Domenech G; Cebrecos J; Pelagio P; Manríquez M; Martínez G; Arcabell M; Cabré F
Arzneimittelforschung; 2011; 61(2):75-9. PubMed ID: 21428240
[TBL] [Abstract][Full Text] [Related]
16. Relative bioavailability and pharmacokinetic comparison of two 2-mg risperidone tablet formulations: A single dose, randomized-sequence, double-blind, 2-way crossover study in healthy male volunteers in Thailand.
Boonleang J; Pipatrattanaseree W; Tanthana C; Mahatthanatrakul W
Clin Ther; 2010 Sep; 32(10):1842-53. PubMed ID: 21194608
[TBL] [Abstract][Full Text] [Related]
17. Comparative pharmacokinetic and bioequivalence study of azithromycin 500 mg tablet in healthy Bangladeshi volunteers.
Ahmed MU; Islam MS; Shohag H; Karim R; Mostofa AG; Bhuiyan NH; Rahim M; Hasnat A
Int J Clin Pharmacol Ther; 2012 Jun; 50(6):452-8. PubMed ID: 22677307
[TBL] [Abstract][Full Text] [Related]
18. Single dose bioequivalence study of two brands of olanzapine 10 mg tablets in Iranian healthy volunteers.
Zakeri-Milani P; Islambulchilar Z; Ghanbarzadeh S; Valizadeh H
Drug Res (Stuttg); 2013 Jul; 63(7):346-50. PubMed ID: 23605469
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and bioavailability studies of 5 mg mosapride tablets in healthy Korean volunteers.
Kim SH; Park YS; Kim JM; Park HJ; Lee MH; Park HK; Kim YJ; Cho SH; Shaw LM; Kang JS
Int J Clin Pharmacol Ther; 2012 Jul; 50(7):524-31. PubMed ID: 22541755
[TBL] [Abstract][Full Text] [Related]
20. In vivo bioequivalence of oral antidiabetic agents: pioglitazone tablets.
Wong H; Ozalp Y; Lainesse A; Alpan RS
Arzneimittelforschung; 2004 Sep; 54(9A):618-24. PubMed ID: 15497670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
